These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30834514)

  • 81. Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis.
    Nawras M; Beran A; Yazdi V; Hecht M; Lewis C
    Int Clin Psychopharmacol; 2023 Jul; 38(4):261-268. PubMed ID: 36752703
    [TBL] [Abstract][Full Text] [Related]  

  • 82. What do the terms "drug-specific response/remission rate" and "placebo" really mean?
    Preskorn SH
    J Psychiatr Pract; 2011 Nov; 17(6):420-4. PubMed ID: 22108399
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials.
    Brown LC; Stanton JD; Bharthi K; Maruf AA; Müller DJ; Bousman CA
    Clin Pharmacol Ther; 2022 Dec; 112(6):1303-1317. PubMed ID: 36111494
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of pharmacogenomics testing guiding on clinical outcomes in major depressive disorder: a systematic review and meta-analysis of RCT.
    Wang X; Wang C; Zhang Y; An Z
    BMC Psychiatry; 2023 May; 23(1):334. PubMed ID: 37173736
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
    Kopschina Feltes P; Doorduin J; Klein HC; Juárez-Orozco LE; Dierckx RA; Moriguchi-Jeckel CM; de Vries EF
    J Psychopharmacol; 2017 Sep; 31(9):1149-1165. PubMed ID: 28653857
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effect of Low-Dose Statins in Addition to Standard Therapy on Brain Perfusion and Neurocognitive Performance in Patients with Major Depressive Disorder.
    Massardo T; Quintana JC; Risco L; Corral S; Spuler J; Vicentini D; Castro-Muñoz G; Riedel B; Villa C; Pereira JI
    Neuropsychobiology; 2022; 81(4):271-285. PubMed ID: 35093946
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Time-lag bias in trials of pediatric antidepressants: a systematic review and meta-analysis.
    Reyes MM; Panza KE; Martin A; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2011 Jan; 50(1):63-72. PubMed ID: 21156271
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The efficacy and tolerability of inhaled nitrous oxide in major depressive disorder: a systematic review and meta-analysis.
    Qiu Y; Li L; Duan A; Wang M; Xie M; Chen Z; Wang Z
    Psychopharmacology (Berl); 2023 Oct; 240(10):2033-2043. PubMed ID: 37608194
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response.
    Lombardo G; Nettis MA; Hastings C; Zajkowska Z; Mariani N; Nikkheslat N; Worrell C; Enache D; McLaughlin A; Kose M; Bogdanova A; Sforzini L; Cleare AJ; Young AH; Dazzan P; Mondelli V; Pariante CM
    Brain Behav Immun Health; 2022 Dec; 26():100561. PubMed ID: 36467125
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Anti-inflammatory Drugs in the Treatment of Depression.
    Cavanagh JT
    Curr Top Behav Neurosci; 2024; 66():217-231. PubMed ID: 38112963
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Efficacy and tolerability of minocycline in depressive patients with or without treatment-resistant: a meta-analysis of randomized controlled trials.
    Qiu Y; Duan A; Yin Z; Xie M; Chen Z; Sun X; Wang Z; Zhang X
    Front Psychiatry; 2023; 14():1139273. PubMed ID: 37342175
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis.
    Du Y; Dou Y; Wang M; Wang Y; Yan Y; Fan H; Fan N; Yang X; Ma X
    Front Psychiatry; 2024; 15():1407529. PubMed ID: 38863604
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inflammatory Biomarker and Response to Antidepressant in Major Depressive Disorder: a Systematic Review and Meta-Analysis.
    Gasparini A; Callegari C; Lucca G; Bellini A; Caselli I; Ielmini M
    Psychopharmacol Bull; 2022 Feb; 52(1):36-52. PubMed ID: 35342200
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Minocycline treatment improves cognitive and functional plasticity in a preclinical mouse model of major depressive disorder.
    Poggini S; Banqueri M; Ciano Albanese N; Golia MT; Ibáñez FG; Limatola C; Furhmann M; Lalowski M; Tremblay ME; Maggi L; Kaminska B; Branchi I
    Behav Brain Res; 2023 Mar; 441():114295. PubMed ID: 36641083
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Antidepressant psychopharmacology: is inflammation a future target?
    Benedetti F; Zanardi R; Mazza MG
    Int Clin Psychopharmacol; 2022 May; 37(3):79-81. PubMed ID: 35357329
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets.
    Kouba BR; de Araujo Borba L; Borges de Souza P; Gil-Mohapel J; Rodrigues ALS
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474387
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Beyond the resistance: how novel neurobiological understandings of depression may lead to advanced treatment strategies.
    Jain R; Jackson WC
    J Clin Psychiatry; 2012 Nov; 73(11):e30. PubMed ID: 23218168
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Efficacy and safety of zuranolone in major depressive disorder: a meta-analysis of factor effect and dose-response analyses.
    Lin YW; Tu YK; Hung KC; Liang CS; Tseng PT; Lin PY; Chia-Cheng Lai E; Hsu CW
    EClinicalMedicine; 2023 Dec; 66():102308. PubMed ID: 38045802
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses.
    Simon MS; Arteaga-Henríquez G; Fouad Algendy A; Siepmann T; Illigens BMW
    Neuropsychiatr Dis Treat; 2023; 19():1-25. PubMed ID: 36636142
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A Review of l-Methylfolate as Adjunctive Therapy in the Treatment of Major Depressive Disorder.
    Maletic V; Shelton R; Holmes V
    Prim Care Companion CNS Disord; 2023 May; 25(3):. PubMed ID: 37192264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.